Published in J Toxicol Environ Health on August 30, 1996
Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts. Crit Rev Toxicol (2014) 0.90
Fenugreek seeds reduce aluminum toxicity associated with renal failure in rats. Nutr Res Pract (2013) 0.80
Aluminum and the human diet revisited. Commun Integr Biol (2013) 0.75
The therapeutic protection of a living and dead Lactobacillus strain against aluminum-induced brain and liver injuries in C57BL/6 mice. PLoS One (2017) 0.75
Biomaterials for craniofacial reconstruction. GMS Curr Top Otorhinolaryngol Head Neck Surg (2011) 0.75
Potential of Lactobacillus plantarum CCFM639 in Protecting against Aluminum Toxicity Mediated by Intestinal Barrier Function and Oxidative Stress. Nutrients (2016) 0.75
The Biomolecular Interaction Network Database and related tools 2005 update. Nucleic Acids Res (2005) 12.94
Natural behavior polymorphism due to a cGMP-dependent protein kinase of Drosophila. Science (1997) 3.82
Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis (1999) 2.65
Effect of silicon on gastrointestinal absorption of aluminium. Lancet (1993) 1.80
Genomic instability induced by ionizing radiation. Radiat Res (1996) 1.73
Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions. N Engl J Med (1997) 1.71
Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2. Nat Biotechnol (2000) 1.66
Inhibition of renal creatinine secretion by cimetidine in humans. Ren Physiol (1982) 1.65
Improved analysis of picomole quantities of lithium, sodium, and potassium in biological fluids. Am J Physiol (1994) 1.57
Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science (1975) 1.49
Variation of glucosinolates in vegetable crops of Brassica oleracea. J Agric Food Chem (1999) 1.48
Comparative pharmacokinetics of cefamandole, cephapirin, and cephalothin in healthy subjects and effect of repeated dosing. Antimicrob Agents Chemother (1976) 1.45
A comparison of the individual and collective effects of four glucosinolate breakdown products from brussels sprouts on induction of detoxification enzymes. Toxicol Appl Pharmacol (1998) 1.44
Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychopharmacology (Berl) (1976) 1.43
The 2000 Canadian recommendations for the management of hypertension: Part one--therapy. Can J Cardiol (2001) 1.42
The mortality of psychoanalysts. J Am Psychoanal Assoc (2001) 1.39
Concerning CERRIE's conclusions and COMARE's response on doses and risks from internal emitters. J Radiol Prot (2005) 1.38
Both positive reinforcement and conditioned aversion from amphetamine and from apomorphine in rats. Science (1976) 1.34
Kinetics of uptake and elimination of silicic acid by a human subject: a novel application of 32Si and accelerator mass spectrometry. J Inorg Biochem (1998) 1.26
Oligomeric but not monomeric silica prevents aluminum absorption in humans. Am J Clin Nutr (2000) 1.24
Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats. Am J Physiol Heart Circ Physiol (2000) 1.22
The nature of the acid-volatile selenium in the liver of the male rat. Biochem J (1973) 1.22
Drug level of d- and l-amphetamine during intravenous self-administration. Psychopharmacologia (1974) 1.21
Antioxidant therapy for recurrent pancreatitis: biochemical profiles in a placebo-controlled trial. Aliment Pharmacol Ther (1992) 1.18
Self-administration of optical isomers of amphetamine and methylamphetamine by rats. J Pharmacol Exp Ther (1973) 1.18
Disruption of the cyclic AMP phosphodiesterase-4 (PDE4)-HSP20 complex attenuates the β-agonist induced hypertrophic response in cardiac myocytes. J Mol Cell Cardiol (2011) 1.14
Elevation of serum aluminum in humans on a two-day sucralfate regimen. J Clin Pharmacol (1987) 1.12
Carotene, tocopherol, and ascorbate contents in subspecies of Brassica oleracea. J Agric Food Chem (1999) 1.12
Office hypertension in type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1991) 1.12
Successful removal of aluminium from patient with dialysis encephalopathy. Lancet (1980) 1.12
Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter. Am J Kidney Dis (2001) 1.11
The pharmacokinetics and blood-brain barrier permeation of the chelators 1,2 dimethly-, 1,2 diethyl-, and 1-[ethan-1'ol]-2-methyl-3-hydroxypyridin-4-one in the rat. Toxicology (1996) 1.11
Withholding life-sustaining treatment: are adolescents competent to make these decisions? CMAJ (2000) 1.10
Solubility and potential toxicity of lead in urban street dust. Bull Environ Contam Toxicol (1979) 1.08
Treatment of fracturing renal osteodystrophy by desferrioxamine. Proc Eur Dial Transplant Assoc (1983) 1.07
β-Arrestin 1 inhibits the GTPase-activating protein function of ARHGAP21, promoting activation of RhoA following angiotensin II type 1A receptor stimulation. Mol Cell Biol (2010) 1.01
Comparison of the bioactivity of two glucoraphanin hydrolysis products found in broccoli, sulforaphane and sulforaphane nitrile. J Agric Food Chem (2001) 1.01
Status and future concerns of clinical and environmental aluminum toxicology. J Toxicol Environ Health (1996) 1.00
Lifestyle changes to prevent and control hypertension: do they work? A summary of the Canadian consensus conference. CMAJ (1999) 0.99
Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ (1997) 0.96
The 2000 Canadian recommendations for the management of hypertension: part two--diagnosis and assessment of people with high blood pressure. Can J Cardiol (2001) 0.92
Aluminium content of milk formulae and intravenous fluids used in infants. Lancet (1986) 0.91
Drug information to patient care areas via television: preliminary evaluation of two years' experience. Spec Libr (1978) 0.91
Gastrointestinal absorption of aluminum is increased in Down's syndrome. Biol Psychiatry (1997) 0.89
Therapy of aluminium overload (II). Contrib Nephrol (1984) 0.89
Aberrant free radical activity in cystic fibrosis. Clin Chim Acta (1989) 0.88
Amphetamine- type reinforcement by dopaminergic agonists in the rat. Psychopharmacology (Berl) (1978) 0.87
The bioavailability of 26Al-labelled aluminium citrate and aluminium hydroxide in volunteers. Biometals (1996) 0.87
4-Trimethylammonium antipyrine: a quaternary ammonium nonradionuclide marker for blood-brain barrier integrity during in vivo microdialysis. J Pharmacol Toxicol Methods (1992) 0.87
Aluminum facilitation of iron-mediated lipid peroxidation is dependent on substrate, pH and aluminum and iron concentrations. Arch Biochem Biophys (1996) 0.87
Binding of lead to a metallothionein-like protein in human erythrocytes. J Inorg Biochem (1993) 0.86
Preparative HPLC method for the purification of sulforaphane and sulforaphane nitrile from Brassica oleracea. J Agric Food Chem (2001) 0.86
Aluminum absorption studied by 26Al tracer. Lancet (1991) 0.86
The biological speciation and toxicokinetics of aluminum. Environ Health Perspect (1994) 0.86
Concurrent intracranial self-stimulation and amphetamine self-administration in rats. Pharmacol Biochem Behav (1977) 0.85
Evaluation of the safety and bioactivity of purified and semi-purified glucoraphanin. Food Chem Toxicol (2007) 0.85
Critical concentrations of aluminium in water used for dialysis. Lancet (1981) 0.85
Effects of dietary phytoestrogen on global myocardial ischemia-reperfusion injury in isolated female rat hearts. Am J Physiol Heart Circ Physiol (2001) 0.84
Speciation of aluminum in biological systems. J Toxicol Environ Health (1996) 0.84
Predictability of theophylline levels. Drug Intell Clin Pharm (1982) 0.83
Short-term treatment with alcohols causes hepatic steatosis and enhances acetaminophen hepatotoxicity in Cyp2e1(-/-) mice. Toxicol Appl Pharmacol (2000) 0.83
Effect of sucralfate on phenytoin bioavailability. Drug Intell Clin Pharm (1986) 0.83
Oral vitamin B(12) and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia. Kidney Int (2001) 0.83
Uptake by man of aluminium in a public water supply. Hum Exp Toxicol (1998) 0.82
The relationship between nickel chloride-induced peroxidation and DNA strand breakage in rat liver. Toxicol Appl Pharmacol (1992) 0.82
Acetaminophen hepatotoxicity precipitated by short-term treatment of rats with ethanol and isopentanol: protection by triacetyloleandomycin. Biochem Pharmacol (2000) 0.82
Renal accumulation and urinary excretion of cisplatin in diabetic rats. Toxicology (1991) 0.81
Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis. Gastroenterology (1988) 0.81
Influence of calcium on aluminum accumulation by the rat jejunal slice. Res Commun Chem Pathol Pharmacol (1988) 0.81
Evidence-based recommendations for the clinical use of recombinant human erythropoietin. Am J Kidney Dis (1995) 0.81
Evaluation of urinary N-acetyl cysteinyl allyl isothiocyanate as a biomarker for intake and bioactivity of Brussels sprouts. Food Chem Toxicol (2003) 0.80
Absorption of aluminium-26 in Alzheimer's disease, measured using accelerator mass spectrometry. Dement Geriatr Cogn Disord (2000) 0.80
Aluminum citrate is transported from brain into blood via the monocarboxylic acid transporter located at the blood-brain barrier. Toxicology (1997) 0.80
Role of CYP3A in ethanol-mediated increases in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol (1997) 0.80
Self-measurement of blood pressure: accuracy, patient preparation for readings, technique and equipment. Blood Press Monit (2001) 0.80
Human metabolism of aluminium-26 and gallium-67 injected as citrates. Hum Exp Toxicol (1995) 0.80
Systemic aluminum toxicity: effects on bone, hematopoietic tissue, and kidney. J Toxicol Environ Health (1996) 0.80
Selenium status in relation to reduced glutathione peroxidase activity in aspirin-sensitive asthma. Clin Exp Allergy (1991) 0.79
Studies on selenium incorporation into, and electron-transfer function of, liver microsomal fractions from normal and vitamin E-deficient rats given phenobarbitone. Biochem J (1973) 0.79
Abuse and pulmonary complications of injecting pentazocine and tripelennamine tablets. Clin Toxicol (1979) 0.79
Aluminum bioavailability and disposition in adult and immature rabbits. Toxicol Appl Pharmacol (1985) 0.79
Aluminum inhibits glutamate release from transverse rat hippocampal slices: role of G proteins, Ca channels and protein kinase C. Neurotoxicology (1992) 0.79
Sodium and potassium levels in antacids. Am J Hosp Pharm (1977) 0.79
Inter-subject variability in the metabolism of aluminium following intravenous injection as citrate. Hum Exp Toxicol (1995) 0.79
Kinetics of aluminum in rats. III: Effect of route of administration. J Pharm Sci (1992) 0.79
Development of an instrument to investigate parents' perceptions of research with newborn babies. Nurs Ethics (2000) 0.79
The introduction of proteins into mammalian cells by electroporation. Methods Mol Biol (1995) 0.79
Use of an aluminium-26 tracer to study the deposition of aluminium species on fish gills following mixing of limed and acidic waters. Analyst (1992) 0.79
Separation of the toxic and glutathione-enhancing effects of the naturally occurring nitrile, cyanohydroxybutene. Fundam Appl Toxicol (1992) 0.78
Intraneuronal aluminum potentiates iron-induced oxidative stress in cultured rat hippocampal neurons. Brain Res (1996) 0.78
Parental presence during anaesthesia induction for outpatient surgery of the infant. Paediatr Anaesth (2000) 0.78
The pharmacokinetics of aspirin in rats and the effect of buffer. J Pharmacokinet Biopharm (1991) 0.78
Enhancement of pancreatic and hepatic glutathione levels in rats during cyanohydroxybutene intoxication. Fundam Appl Toxicol (1990) 0.78
Bone aluminium content in Alzheimer's disease. Dementia (1995) 0.78
Simultaneous sampling of blood, bile, and urine in rats for pharmacokinetic studies. J Pharmacol Methods (1990) 0.78
Oral flecainide pharmacokinetics in patients with impaired renal function. J Clin Pharmacol (1988) 0.78
Role of metallothionein in biliary metal excretion. J Toxicol Environ Health (1989) 0.78
Probing the role of glutamic acid 144 in the EcoRI endonuclease using aspartic acid and glutamine replacements. J Biol Chem (1990) 0.78